Excited to represent CarboHyde at the DDF Summit in Berlin!

Our Lead Formulation Expert, Balázs Attila Kondoros, will be attending the upcoming Drug Delivery & Formulation (DDF) Summit in Berlin, where he’ll be diving into the latest innovations in drug delivery technologies.

At CarboHyde, we are particularly interested in exploring how emerging challenges in formulation and delivery could be addressed using cyclodextrins — unlocking new possibilities for solubility, stability, and bioavailability.

Balazs is looking forward to connecting with fellow experts, exchanging ideas, and identifying collaboration opportunities.

Do you want to learn more about Carbo and cyclodextrins?

Who else will be attending? Let’s connect in Berlin!

22nd International Cyclodextrin Symposium

Moga, Punjab, India – ISF College of Pharmacy (An Autonomous College), Moga, is proud to announce that it will host the 22nd International Cyclodextrin Symposium (ICS22) from October 22-26, 2026. This marks a historic milestone as the first time this prestigious international symposium is being held in India.

The symposium, themed “Integrating Cyclodextrin and AI Techniques for Next-Generation Novel Drug Delivery Systems,” will bring together more than 500 leading scientists, researchers, academicians, and industry professionals from over 40 countries to discuss groundbreaking advances in cyclodextrin chemistry and its revolutionary applications in pharmaceutical sciences.

The symposium will cover diverse topics including:
# Cyclodextrin chemistry and characterization
# Novel drug delivery systems
# AI and machine learning in pharmaceutical formulation
# Nanotechnology applications
# Industrial perspectives and commercialization
# Regulatory aspects and quality control
# Clinical applications and case studies

22nd International Cyclodextrin Symposium

22nd International Cyclodextrin Symposium

Moga, Punjab, India – ISF College of Pharmacy (An Autonomous College), Moga, is proud to announce that it will host the 22nd International Cyclodextrin Symposium (ICS22) from October 22-26, 2026. This marks a historic milestone as the first time this prestigious international symposium is being held in India.

The symposium, themed “Integrating Cyclodextrin and AI Techniques for Next-Generation Novel Drug Delivery Systems,” will bring together more than 500 leading scientists, researchers, academicians, and industry professionals from over 40 countries to discuss groundbreaking advances in cyclodextrin chemistry and its revolutionary applications in pharmaceutical sciences.

The symposium will cover diverse topics including:
# Cyclodextrin chemistry and characterization
# Novel drug delivery systems
# AI and machine learning in pharmaceutical formulation
# Nanotechnology applications
# Industrial perspectives and commercialization
# Regulatory aspects and quality control
# Clinical applications and case studies

When Cyclodextrin’s Two Homes Met in Kyoto

Last week, Kyoto hosted the 12th Asian Cyclodextrin Conference, bringing together researchers, collaborators, and long-time friends from around the world — including several members of Bicyclos HEurope.

For us at CarboHyde, the event felt like a reunion between the two main “homes” of cyclodextrin science.
Japan has long been a cradle of CD innovation, while Hungary has become another strong home driving cyclodextrins toward new applications and industries. Seeing these two hubs reconnect in Kyoto was inspiring.

Our CSO, Milo Malanga, PhD, was also present — the smiling, chatty Italian in jeans who never misses the chance to ask a sharp question after each lecture. His presence helped spark new conversations and strengthen ongoing collaborations.

The conference offered what makes this community so special: solid science, meaningful dialogue, and friendships that push the field forward.

We return from Kyoto with renewed motivation — ready to turn last week’s ideas into future cyclodextrin innovations.

Connecting biotechnology, agriculture, and pharmaceuticals

We at CarboHyde are proud to see our collaboration with Allbiom – Inteligência em Bioprocessos represented at the CIFARP – International Congress of Pharmaceutical Sciences!

The joint research presented by Lilian Pontes and Amanda Brandão, under the leadership of Dr. Ana Carolina Ré, beautifully demonstrates how cyclodextrins can serve as molecular bridges between agro- and pharma-biotechnology — enabling smarter delivery systems, modulation of microbial processes, and new bioproduction strategies.

This collaboration reflects CarboHyde’s mission to expand the application horizon of cyclodextrins beyond traditional boundaries — harnessing their supramolecular chemistry to open new routes in sustainable innovation.

A big thank you to our partners at Allbiom for their scientific excellence and inspiring teamwork. We’re excited to see where this synergy will lead next!

Annual Symposium on Pharmaceutical Chemistry and Pharmaceutical Technology

While part of the team last week was at EuroCD, Tamas Kiss, PhD was also busy.

We had the privilege to present interesting applications of cyclodextrins in the Annual Symposium on Pharmaceutical Chemistry and Pharmaceutical Technology, organized by the Hungarian Chemical Society.

The lecture presented several fascinating cyclodextrin applications, such as:

1. Cyclarity Therapeutics’ solution for reversing arteriosclerosis with a cyclodextrin dimer (they are in Clinical Phase 1)

2. Oculis’ formulation that contains gamma-cyclodextrin-dexamethasone suspension, which could be an alternative to the intravitreal injection (Clinical Phase 3 completed)

3. Fraunhofer Institute for Building Physics IBP’s gel, which binds the toxic vapour (e.g., lindane) that is released from wood preservatives widespread in Germany

Hidden cyclodextrin innovations

Last week at the EuroCD-25, I talked about how the innovation landscape is changing in the cyclodextrin field.

What was dominated by pharma 20-30-40 years ago is getting taken over by non-pharma these days.

New derivatives (like polymers or conjugates) and innovative drug delivery solutions (like MOFs) emerge and get commercialized in cosmetic, environmental, household and nutraceutical uses.

My talk was not only describing the case studies but also analyzing what was the key to their success, what enabled them to be successful in the market.

In your opinion – what is the key for successful innovation?

Annual Symposium on Pharmaceutical Chemistry and Pharmaceutical Technology in 2025

While part of the team last week was at EuroCD, Tamas Kiss, PhD was also busy.

We had the privilege to present interesting applications of cyclodextrins in the Annual Symposium on Pharmaceutical Chemistry and Pharmaceutical Technology, organized by the Hungarian Chemical Society.

The lecture presented several fascinating cyclodextrin applications, such as:

1. Cyclarity Therapeutics’ solution for reversing arteriosclerosis with a cyclodextrin dimer (they are in Clinical Phase 1)

2. Oculis’ formulation that contains gamma-cyclodextrin-dexamethasone suspension, which could be an alternative to the intravitreal injection (Clinical Phase 3 completed)

3. Fraunhofer Institute for Building Physics IBP’s gel, which binds the toxic vapour (e.g., lindane) that is released from wood preservatives widespread in Germany